SG10201903292SA - A drug delivery composition - Google Patents

A drug delivery composition

Info

Publication number
SG10201903292SA
SG10201903292SA SG10201903292SA SG10201903292SA SG10201903292SA SG 10201903292S A SG10201903292S A SG 10201903292SA SG 10201903292S A SG10201903292S A SG 10201903292SA SG 10201903292S A SG10201903292S A SG 10201903292SA SG 10201903292S A SG10201903292S A SG 10201903292SA
Authority
SG
Singapore
Prior art keywords
drug delivery
delivery composition
aquatic animal
composition
delivering
Prior art date
Application number
SG10201903292SA
Inventor
George Saji
Eng Khuan Seng
Original Assignee
Nanyang Polytechnic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanyang Polytechnic filed Critical Nanyang Polytechnic
Priority to SG10201903292SA priority Critical patent/SG10201903292SA/en
Publication of SG10201903292SA publication Critical patent/SG10201903292SA/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A DRUG DELIVERY COMPOSITION This invention relates to a drug delivery composition. In particular, the invention relates to a drug delivery composition for delivering a drug to an aquatic animal. More particularly, but not exclusively, the drug delivery composition is capable of delivering an immunogenic antigen to an aquatic animal to induce an immune response in the aquatic animal. The 10 composition comprising: (a) a nanoparticle; and (b) the active ingredient contained in said nanoparticle. A method for preparing the drug delivery composition and method of delivering a drug composition to an aquatic animal or inducing an immune response in an aquatic animal are also disclosed. 15 (No suitable figure) 25
SG10201903292SA 2015-03-27 2015-03-27 A drug delivery composition SG10201903292SA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG10201903292SA SG10201903292SA (en) 2015-03-27 2015-03-27 A drug delivery composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201903292SA SG10201903292SA (en) 2015-03-27 2015-03-27 A drug delivery composition

Publications (1)

Publication Number Publication Date
SG10201903292SA true SG10201903292SA (en) 2019-05-30

Family

ID=66673841

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201903292SA SG10201903292SA (en) 2015-03-27 2015-03-27 A drug delivery composition

Country Status (1)

Country Link
SG (1) SG10201903292SA (en)

Similar Documents

Publication Publication Date Title
ZA201902584B (en) Cannabis extracts and methods of preparing and using same
MX2019012081A (en) Human fibroblast growth factor 21 (hfgf21) fusion protein, preparation method therefor, and use thereof.
SG11201808019WA (en) Edaravone formulations
MX2016015179A (en) A liquid formulation comprising nicotine for aerosol administration.
MX2018002627A (en) Crystallization method and bioavailability.
WO2015018380A3 (en) Therapeutic nanoparticles and the preparation methods thereof
EP4382164A3 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
MX2019003988A (en) Nanoparticle formulations and methods of making and using thereof.
MX2018004616A (en) Cosmetic composition having probiotic bacteria.
MX358782B (en) Expression of chimeric ksac protein and method of producing soluble proteins by high pressure.
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
MX2019000381A (en) Formulation for administration of rna.
WO2017044803A8 (en) Expression vector delivery system and use thereof for inducing an immune response
MX2017003121A (en) Antibody formulations.
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
EP3141242A3 (en) Oral dosage form
MX2021013109A (en) Process for preparing an attenuated tetravalent dengue vaccine.
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
MX2018012618A (en) Oral pharmaceutical compositions of mesalazine.
EA201792512A1 (en) COMPOSITIONS FOR DELIVERY OF ANTIGENS OF RESPIRATORY SYNTICIAL VIRUS AND NOROVIRUS INTO THE THIN INTESTINE
MX2019006773A (en) Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs.
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use